Literature DB >> 18008074

Radiofrequency ablation of lung metastases: factors influencing success.

Alice R Gillams1, William R Lees.   

Abstract

This paper analyses the factors associated with successful radiofrequency ablation (RFA) of lung metastases. The study group comprised 37 patients [19 female, mean age 61 (34-83)] with 72 metastases who had follow-up CT scans available for analysis and for those with no recurrence >6 months follow-up. Internally cooled electrodes were used in 64 and expandable electrodes in 8. The tumour size and location, electrode type, number of ablations, duration of ablation, year of treatment and tumour contact with vessels larger than 3 mm were recorded. The mean tumour diameter was 1.8 cm (0.4-6.6 cm). Mean follow-up in those without recurrence was 13.1 months (6-48). Recurrence was common in larger tumours, occurring in 7/7 (100%) tumours >3.5 cm compared with 18/65 (28%) < or = 3.5 cm (P < 0.01). Recurrence occurred in 14/24 (58%) tumours in direct contact with large vessels compared with 11/48 (23%) of the remainder (P = 0.04). On multivariate analysis, size was the dominant feature (P = 0.013); vessel contact and peripheral location did not reach significance (P = 0.056 and 0.054 respectively). Peripheral tumours less than 3.5 cm with no large vessel contact are the optimal tumours for RFA.

Entities:  

Mesh:

Year:  2007        PMID: 18008074     DOI: 10.1007/s00330-007-0811-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.

Authors:  Koichiro Yamakado; Soichiro Hase; Toshiyuki Matsuoka; Noboru Tanigawa; Atsuhiro Nakatsuka; Haruyuki Takaki; Motoshi Takao; Yoshihiro Inoue; Susumu Kanazawa; Yuichi Inoue; Satoshi Sawada; Masato Kusunoki; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2007-03       Impact factor: 3.464

2.  Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival.

Authors:  Tristan D Yan; Julie King; Adrian Sjarif; Derek Glenn; Karin Steinke; David L Morris
Journal:  Ann Surg Oncol       Date:  2006-09-29       Impact factor: 5.344

3.  Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.

Authors:  Thierry de Baère; Jean Palussière; Anne Aupérin; Antoine Hakime; Mohamed Abdel-Rehim; Michèle Kind; Clarisse Dromain; Alain Ravaud; Nathalie Tebboune; Valérie Boige; David Malka; Clarisse Lafont; Michel Ducreux
Journal:  Radiology       Date:  2006-08       Impact factor: 11.105

4.  CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer--a preliminary report of 33 patients.

Authors:  Giuseppe Belfiore; Giovanni Moggio; Enrico Tedeschi; Michele Greco; Riccardo Cioffi; Francesca Cincotti; Renato Rossi
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

5.  Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience.

Authors:  Kotaro Yasui; Susumu Kanazawa; Yoshifumi Sano; Toshiyoshi Fujiwara; Shunsuke Kagawa; Hidefumi Mimura; Shuichi Dendo; Takashi Mukai; Hiroyasu Fujiwara; Toshihiro Iguchi; Tsuyoshi Hyodo; Nobuyoshi Shimizu; Noriaki Tanaka; Yoshio Hiraki
Journal:  Radiology       Date:  2004-04-22       Impact factor: 11.105

6.  Radiofrequency ablation of 40 lung neoplasms: preliminary results.

Authors:  Cosmo Gadaleta; Vittorio Mattioli; Giuseppe Colucci; Antonio Cramarossa; Vito Lorusso; Eugenio Canniello; Artur Timurian; Girolamo Ranieri; Gianmaria Fiorentini; Mario De Lena; Annamaria Catino
Journal:  AJR Am J Roentgenol       Date:  2004-08       Impact factor: 3.959

7.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Pulmonary radiofrequency ablation--an international study survey.

Authors:  Karin Steinke; Patrick E Sewell; Damien Dupuy; Riccardo Lencioni; Thomas Helmberger; Stephen T Kee; Augustinus L Jacob; Derek W Glenn; Julie King; David L Morris
Journal:  Anticancer Res       Date:  2004 Jan-Feb       Impact factor: 2.480

9.  Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.

Authors:  Masao Akeboshi; Koichiro Yamakado; Atsuhiro Nakatsuka; Osamu Hataji; Osamu Taguchi; Motoshi Takao; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2004-05       Impact factor: 3.464

Review 10.  Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: current status.

Authors:  A D Kelekis; L Thanos; S Mylona; N Ptohis; K Malagari; A Nikita; J Christodoulidou; N Kelekis
Journal:  Eur Radiol       Date:  2006-05-16       Impact factor: 7.034

View more
  35 in total

Review 1.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 2.  The role of percutaneous image-guided ablation for lung tumors.

Authors:  Elena N Petre; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Radiol Med       Date:  2014-07-01       Impact factor: 3.469

Review 3.  Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances.

Authors:  S L Smith; P E Jennings
Journal:  Br J Radiol       Date:  2014-12-03       Impact factor: 3.039

Review 4.  Thermal ablation of stage I non-small cell lung carcinoma.

Authors:  Carol A Ridge; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 5.  Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?

Authors:  Millie Das; Mohamed H K Abdelmaksoud; Billy W Loo; Nishita Kothary
Journal:  Curr Treat Options Oncol       Date:  2010-06

Review 6.  From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel.

Authors:  Chunxia Su; Mathias Meyer; Robert Pirker; Wieland Voigt; Jingyun Shi; Lothar Pilz; Rudolf M Huber; Yilong Wu; Jinghong Wang; Yonglan He; Xuan Wang; Jian Zhang; Xiuyi Zhi; Meiqi Shi; Bo Zhu; Stefan S Schoenberg; Thomas Henzler; Christian Manegold; Caicun Zhou; Eric Dominic Roessner
Journal:  Transl Lung Cancer Res       Date:  2016-08

7.  Understanding the possibility of image-guided thermal ablation for pulmonary malignancies.

Authors:  Hideki Ujiie; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

8.  The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy.

Authors:  Yoshio Naya; Terukazu Nakamura; Masakatsu Oishi; Takashi Ueda; Hiroyuki Nakanishi; Yasuyuki Naitoh; Fumiya Hongo; Kazumi Kamoi; Koji Okihara; Osamu Tanaka; Takuji Yamagami; Kei Yamada; Tsuneharu Miki
Journal:  Int J Clin Oncol       Date:  2015-04-30       Impact factor: 3.402

Review 9.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 10.  Tumour ablation: current role in the kidney, lung and bone.

Authors:  Alice Gillams
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.